Gregory Wilding

Gregory Wilding, PhD, is a Professor and Chair in the Department of Biostatistics at the University at Buffalo's School of Public Health and Health Professions. He also holds academic appointments at Roswell Park Comprehensive Cancer Center, where he advanced from Associate Biostatistics Consultant (2004) to Associate Professor (2009) and Professor (2015). His expertise spans biostatistical methodology, clinical trial design, and statistical inference in healthcare research.

Education:

• PhD in Statistics, University of Rochester
• MA in Statistics, University of Rochester
• BS in Mathematics, Business Administration, and Computer Science, SUNY Brockport

Research Interests: Dr. Wilding focuses on statistical methods for clinical trials, including permutation tests, resampling techniques, and copula-based analyses. His work emphasizes applications in neurology (e.g., multiple sclerosis imaging biomarkers), oncology (e.g., vaccine adjuvant efficacy), and mental health (e.g., insomnia interventions in veterans and cancer survivors). He also explores genetic and pharmacokinetic factors influencing treatment outcomes in renal transplantation and chronic diseases.

Publications: Recent work highlights methodological advancements in clinical trial design, including paramagnetic lesion endpoint modeling in MS and lithium efficacy in neurodegenerative conditions. His studies span telemedicine reliability, behavioral therapy for comorbid insomnia/PTSD, and CHRFAM7A gene function in immune adaptation.

Advising/Grants: While specific grant details are not provided, his leadership positions suggest significant involvement in funded research. His mentorship is reflected in collaborative projects with clinicians, psychologists, and geneticists.

Labs/Teams: Affiliated with interdisciplinary teams at Roswell Park and UB, focusing on translational biostatistics and clinical research innovation.